brooks nader glp 1 Says Her GLP-1 Use Stems From Her 'Confidence Journey' (Excl) Brooks Nader Reveals She's Become
Description
Not to reject progress, but to claim ownership of its risks
Timeframe: Current performance (2025) and near-term forecasts (2026), with long-term projections extending to 2035 EmarketerYahoo
In a study published in May, researchers used a large patient dataset to compare the NAION rate within 1 year of adults with Type 2 diabetes starting GLP-1 treatment (like Ozempic) versus those starting dipeptidyl peptidase 4 inhibitors
National Heart Lung and Blood Institute
Mounjaro is a once-weekly injectable medication originally developed for type 2 diabetes management
and (v) differences in blinding and reporting standards
